92 related articles for article (PubMed ID: 15170499)
1. Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes.
Owen KR; Evans JC; Frayling TM; Hattersley AT; McCarthy MI; Walker M; Hitman GA
Diabetologia; 2004 May; 47(5):957-8. PubMed ID: 15170499
[No Abstract] [Full Text] [Related]
2. Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population.
Gragnoli C; Cronsell J
Minerva Med; 2007 Jun; 98(3):163-6. PubMed ID: 17592437
[TBL] [Abstract][Full Text] [Related]
3. Association of rs12255372 (TCF7L2) and D76N (PDX-1) Polymorphisms with Type 2 Diabetes in a Population Living in Northeast Iran.
Rafati R; Jalal R; Asoodeh A; Matin MM
Arch Iran Med; 2015 Jun; 18(6):376-8. PubMed ID: 26058934
[TBL] [Abstract][Full Text] [Related]
4. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
Elbein SC; Karim MA
Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
[TBL] [Abstract][Full Text] [Related]
5. A newly identified mutation in an IPF1 binding site of the insulin gene promoter may predispose to type 2 diabetes mellitus.
Malecki MT; Lebrun P; Pezzolesi M; Warram JH; Krolewski AS; Jhala US
Diabetologia; 2006 Aug; 49(8):1985-7. PubMed ID: 16741735
[No Abstract] [Full Text] [Related]
6. Gene symbol: IPF1. Disease: MODY 4.
Cockburn BN; Bermano G; Boodram LL; Teelucksingh S; Tsuchiya T; Mahabir D; Allan AB; Stein R; Docherty K; Bell GI
Hum Genet; 2005 May; 116(6):538. PubMed ID: 15991313
[No Abstract] [Full Text] [Related]
7. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
[TBL] [Abstract][Full Text] [Related]
8. Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.
Edghill EL; Khamis A; Weedon MN; Walker M; Hitman GA; McCarthy MI; Owen KR; Ellard S; T Hattersley A; Frayling TM
Diabet Med; 2011 Jun; 28(6):681-4. PubMed ID: 21569088
[TBL] [Abstract][Full Text] [Related]
9. Identification of a single nucleotide insertion polymorphism in the upstream region of the insulin promoter factor-1 gene: an association study with diabetes mellitus.
Yamada K; Yuan X; Ishiyama S; Ichikawa F; Kohno S; Shoji S; Hayashi H; Nonaka K
Diabetologia; 1998 May; 41(5):603-5. PubMed ID: 9628281
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology. HNFs--linking the liver and pancreatic islets in diabetes.
Kulkarni RN; Kahn CR
Science; 2004 Feb; 303(5662):1311-2. PubMed ID: 14988544
[No Abstract] [Full Text] [Related]
12. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
[TBL] [Abstract][Full Text] [Related]
13. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians.
Chèvre JC; Hani EH; Stoffers DA; Habener JF; Froguel P
Diabetes; 1998 May; 47(5):843-4. PubMed ID: 9588460
[No Abstract] [Full Text] [Related]
14. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1.
Thomas MK; Devon ON; Lee JH; Peter A; Schlosser DA; Tenser MS; Habener JF
J Clin Invest; 2001 Jul; 108(2):319-29. PubMed ID: 11457885
[TBL] [Abstract][Full Text] [Related]
15. [Genetic variations of urotensin II gene in type 2 diabetes].
Hinokio Y; Suzuki S; Oka Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():193-7. PubMed ID: 15779369
[No Abstract] [Full Text] [Related]
16. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
[TBL] [Abstract][Full Text] [Related]
17. No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in Type II diabetes in France.
Dupont S; Vionnet N; Chèvre JC; Gallina S; Dina C; Seino Y; Yamada Y; Froguel P
Diabetologia; 1999 Apr; 42(4):480-4. PubMed ID: 10230653
[TBL] [Abstract][Full Text] [Related]
18. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1.
Stoffers DA; Ferrer J; Clarke WL; Habener JF
Nat Genet; 1997 Oct; 17(2):138-9. PubMed ID: 9326926
[No Abstract] [Full Text] [Related]
19. Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects.
Hara M; Lindner TH; Paz VP; Wang X; Iwasaki N; Ogata M; Iwamoto Y; Bell GI
Diabetes; 1998 May; 47(5):845-6. PubMed ID: 9588461
[No Abstract] [Full Text] [Related]
20. Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes.
Matsubara A; Wasson JC; Donelan SS; Welling CM; Glaser B; Permutt MA
Diabetologia; 2001 Jul; 44(7):910-3. PubMed ID: 11508278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
